CasLoc logo
All Cases PTAB Litigations UPC Oppositions

AbbVie Inc. v. Hetero USA Inc.

1:13-cv-00852

Overview

Case Number 1:13-cv-00852
Filing Date 2013-05-15
Status Terminated
Termination Date 2014-11-18
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

AbbVie Inc. Operating Company

Represented By

5 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jennifer A. Johnson

Email: jennifer.johnson@finnegan.com

Mary B. Graham

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Barbara R. Rudolph

Email: barbara.rudolph@finnegan.com

Corinne Miller LaGosh

UNDELIVERABLE EMAIL 10/7/15

Plaintiff

Abbvie Deutschland GMBH & Co. KG Operating Company

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Mary B. Graham

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Counter Claimant

Hetero Labs Limited NPE (University / Research)

Represented By

1 Attorneys Listed

Dominick T. Gattuso

Heyman Enerio Gattuso & Hirzel LLP

Tel: +1 (302) 472-7311
Fax: +1 (302) 472-7301

300 Delaware Avenue, Suite 200, Wilmington, DE 19801

Hetero USA Inc. Operating Company

Represented By

6 Attorneys Listed

Magdalena Spencer

Email: mspencer@axinn.com

Diane C. Ragosa

UNDELIVERABLE EMAIL 3/3/15

Delphine W. Knight Brown

Email: dknightbrown@axinn.com

Josephine Liu

UNDELIVERABLE EMAIL 4/10/14

Chad A. Landmon

Email: clandmon@axinn.com

Dominick T. Gattuso

Heyman Enerio Gattuso & Hirzel LLP

Tel: +1 (302) 472-7311
Fax: +1 (302) 472-7301

300 Delaware Avenue, Suite 200, Wilmington, DE 19801

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 7 proceedings
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (7 found):
U.S. Courts: 7
U.S. District Court 2017-01-13
1:17-cv-00047

AbbVie Inc. v. Aurobindo Pharma Limited

Asserted Patent
Status: DED
U.S. District Court 2016-05-27
1:16-cv-00398

AbbVie Inc. v. Amneal Pharmaceuticals, LLC

Asserted Patent
Status: DED
U.S. District Court 2015-10-02
1:15-cv-00889

AbbVie Inc. v. Hetero USA Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-07-18
1:14-cv-00959

AbbVie Inc. v. Aurobindo Pharma Limited

Asserted Patent
Status: DED
U.S. District Court 2013-07-03
2:13-cv-00645

AbbVie Inc. v. Roxane Laboratories Inc.

Asserted Patent
Status: OHSD
U.S. District Court 2013-06-14
1:13-cv-01072

AbbVie Inc. v. Mylan Pharmaceuticals Inc.

Asserted Patent
Status: DED
U.S. District Court 2012-04-10
1:12-cv-00457

AbbVie Inc. v. Roxane Laboratories Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

6 Patents

There are 6 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7148359
Polymorph of a pharmaceutical
Filed: 2005-05-04
Issued: 2006-12-12
Expired (Term Ended)
Expires: 2025-05-04
US7364752
Solid dispersion pharamaceutical formulations
Filed: 2000-11-10
Issued: 2008-04-29
Expired (Term Ended) +688d PTA
Expires: 2022-09-29
US8268349
Solid pharmaceutical dosage form
Filed: 2012-04-18
Issued: 2012-09-18
Active (5.4 yrs remaining)
Expires: 2032-04-18
US6037157
Method for improving pharmacokinetics
Filed: 1996-06-26
Issued: 2000-03-14
Expired (Term Ended)
Expires: 2016-06-26
US6703403
Method for improving pharmacokinetics
Filed: 2001-09-20
Issued: 2004-03-09
Expired (Term Ended)
Expires: 2016-09-09

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

15

Dispositive

0

Granted

0

Denied

0

Pending / Review

12

Motions by Category

Claim Construction / Markman Filing 11 Procedural / Extension Motion 4

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
Joint STIPULATION TO EXTEND TIME for Certain Scheduling Order Deadlines - filed by Hetero Labs Limited, Hetero USA Inc.. (Gattuso, Dominick) Modified on 11/7/20...
Entry #96 • 2014-11-07 Document →
Claim Construction / Markman Filing Pending
SO ORDERED Granting 96 Joint STIPULATION TO EXTEND TIME for Certain Scheduling Order Deadlines, filed by Hetero USA Inc., Hetero Labs Limited (Reset Deadlines: ...
Entry #— • 2014-11-07
Claim Construction / Markman Filing Pending
SO ORDERED re 95 Joint STIPULATION TO EXTEND TIME for Certain Scheduling Order Deadlines, filed by Hetero USA Inc., Hetero Labs Limited (Reset Deadlines: Joint ...
Entry #— • 2014-10-31
Procedural / Extension Motion Pending / Under Review
Joint STIPULATION TO EXTEND TIME for Certain Scheduling Order Deadlines to See Stipulation for Dates - filed by Hetero Labs Limited, Hetero USA Inc.. (Gattuso, ...
Entry #95 • 2014-10-30 Document →
Claim Construction / Markman Filing Pending / Under Review
NOTICE OF SERVICE of Plaintiffs' Opening Claim Construction Brief filed by AbbVie Inc., Abbvie Deutschland GMBH & Co. KG.(Fahnestock, Derek) (Entered: 10/06/201...
Entry #88 • 2014-10-06 Document →
Claim Construction / Markman Filing Pending / Under Review
Joint CLAIM Construction Chart, Volume 1 of 2, by AbbVie Inc., Abbvie Deutschland GMBH & Co. KG. (Attachments: # 1 Part 1, # 2 Part 2, # 3 Part 3, # 4 Part 4, #...
Entry #79 • 2014-09-16 Document →

Docket Entries

(102 total)
Pleading / Complaint

COMPLAINT - filed against Hetero Labs Limited, Hetero USA Inc.. Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1290164.) - filed by AbbVie Inc.. (Attachments: # 1 Exhibit A-F, # 2 Exhibit G-K, # 3 Civil Cover Sheet)(mdb) (Entered: 05/16/2013)

Entry #1 • 2013-05-15
1
Pleading / Complaint

COMPLAINT - filed against Hetero Labs Limited, Hetero USA Inc.. Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1290164.) - filed by AbbVie Inc.. (Attachments: # 1 Exhibit A-F, # 2 Exhibit G-K, # 3 Civil Cover Sheet)(mdb) (Entered: 05/16/2013)

Entry #1 • 2013-05-15
2
Pleading / Complaint

COMPLAINT - filed against Hetero Labs Limited, Hetero USA Inc.. Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1290164.) - filed by AbbVie Inc.. (Attachments: # 1 Exhibit A-F, # 2 Exhibit G-K, # 3 Civil Cover Sheet)(mdb) (Entered: 05/16/2013)

Entry #1 • 2013-05-15
2
Pleading / Complaint

COMPLAINT - filed against Hetero Labs Limited, Hetero USA Inc.. Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1290164.) - filed by AbbVie Inc.. (Attachments: # 1 Exhibit A-F, # 2 Exhibit G-K, # 3 Civil Cover Sheet)(mdb) (Entered: 05/16/2013)

Entry #1 • 2013-05-15
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (mdb) (Entered: 05/16/2013)

Entry #2 • 2013-05-15
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc